New Gut Microbiome Research Targets Portal Hypertension Dr David Johnson explores recent data with urolithin A, a gut metabolite that’s shown early promise in studies with portal hypertension.
Dr David Johnson highlights some key studies. Medscape Gastroenterology, October 25, 2018 ACG 2018 Read clinically focused news coverage of key developments from ACG 2018. Medscape ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback